2012 annual financial data
Relmada Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -95.27%.
Operating income was -12,052 USD and net income was -12,052 USD.
Operating cash flow was -7,565 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,941 USD
- Operating income
- -12,052 USD
- Net income
- -12,052 USD
- Operating cash flow
- -7,565 USD